ENO2 and neoplasm: The diagnostic use of serum tumor markers is reported in the minority of studies, and the data is conflicting: the classic ovarian markers like CA19.9, CEA, and CA-125 can vary greatly, as well as the neuroendocrine markers, such as chromogranin A and NSE, since they are either reported as elevated, or within the normal range [3,8].